Fluoroquinolones: ciprofloxacin, levofloxacin, moxifloxacin, norfloxacin and ofloxacin. Aminoglycosides: amikacin, gentamicin, netilmicin and tobramycin. Glycopeptides: teicoplanin and vancomycin. Other agents: linezolid, daptomycin and tigecycline.
It is the intention of the BSAC and the Journal of Antimicrobial Chemotherapy to publish this document annually. However, as with all methods, it will require constant review and updating. We therefore advise that all interested parties frequently consult the BSAC website (http://www.bsac.org.uk) where the latest updates will be made available. 
Introduction
The BSAC Guide to Sensitivity Testing was first published in 1991 and one of its most important sections was that dealing with breakpoints for clinically relevant bacteria. 2 These breakpoints have been used extensively to interpret MIC results and for single concentration 'breakpoint' tests. However, a criticism of the guidelines was that they did not provide a standardized method of disc diffusion testing with zone limits that correlated with these MIC breakpoints. The limitations of the widely used Stokes' comparative method were also a cause for concern.
The task of developing such a method of disc testing is immense and the Working Party and the Council of the BSAC needed evidence that there was sufficient interest to warrant the investment required not only in the short term, but also for continuing support and development. This necessary confirmation was obtained from a questionnaire survey, 3 which indicated that 90.6% of UK laboratories would be prepared to switch to an upgraded disc test, and the development and 'field testing' of the standardized method were therefore undertaken. 4 Fortuitously, the introduction of the standardized method has coincided with the availability of automated zone measuring devices, which aid measuring and interpretation considerably. With laboratories using the same method, there is a real opportunity to combine zone diameter data, so that levels of resistance in the UK and Ireland can be surveyed and subtle changes in susceptibility detected.
The method, like all standardized disc tests, cannot be adapted by the user, with the exception that various methods of inoculum preparation can be used to achieve semi-confluent growth.
For microorganisms not included in this document, work is either ongoing (e.g. anaerobes) or reported elsewhere (e.g. mycobacteria). 5 1 Preparation of plates 1.1 Prepare Iso-Sensitest agar (ISA; Oxoid, Basingstoke, UK) or media shown to have the same performance as ISA, according to the manufacturer's instructions. Supplement media for fastidious organisms with 5% defibrinated horse blood or 5% defibrinated horse blood and 20 mg/L b-nicotinamide adenine dinucleotide (NAD) as indicated in Table 1 . Use Columbia agar with 2% NaCl for methicillin/oxacillin susceptibility testing of staphylococci. 1.2 Pour sufficient molten agar into sterile Petri dishes to give a depth of 4 + 0.5 mm (25 mL in a 90 mm Petri dish). 1.3 Dry the surface of the agar to remove excess moisture before use. The length of time needed to dry the surface of the agar depends on the drying conditions, e.g. whether a fan-assisted drying cabinet or 'still air' incubator is used, whether plates are dried before storage and storage conditions. It is important that plates are not over-dried. 1.4 Store the plates in vented plastic boxes at 8-108C prior to use. Alternatively, the plates may be stored at 4 -88C in sealed plastic bags. Plate drying, method of storage and storage time should be determined by individual laboratories as part of their quality assurance programme. In particular, quality control tests The information in italics is tentative. Breakpoints will remain tentative for 1 year from when first published. The information in italics is tentative. Breakpoints will remain tentative for 1 year from when first published. a Staphylococci exhibiting resistance to methicillin/oxacillin/cefoxitin should be regarded as resistant to other penicillins, cephalosporins, carbapenems and combinations of b-lactam and b-lactamase inhibitors. Some hyper-producers of b-lactamase give zones within the range of 7-14 mm and, if possible, should be checked by a PCR method for mecA or a latex agglutination test for PBP2a. Increase in the methicillin/oxacillin zone size in the presence of clavulanic acid is not a reliable test for hyper-producers of b-lactamase as zones of inhibition with some MRSA also increase in the presence of clavulanic acid. Rarely, hyper-producers of b-lactamase give no zone in this test and would therefore not be distinguished from MRSA. b MIC breakpoints relate to high-dose therapy (750 mg oral twice daily should confirm that excess surface moisture is not produced and that plates are not over-dried.
Selection of control organisms
2. 1 The performance of the tests should be monitored by the use of appropriate control strains. The control strains listed (Tables 2 and 3 ) include susceptible strains that have been chosen to monitor test performance and resistant strains that can be used to confirm that the method will detect phenotypically resistant isolates. 2.2 Store control strains at 2708C on beads in glycerol broth. Non-fastidious organisms may be stored at 2208C. Two vials of each control strain should be stored: one for an 'in-use' supply and the other for archiving. 2.3 Every week subculture a bead from the 'in-use' vial onto appropriate non-selective media and check for purity. From this pure culture, prepare one subculture on each of the following 5 days. For fastidious organisms that will not survive on plates for 5/6 days, subculture the strain daily for no more than 6 days.
Preparation of inoculum
The inoculum should give semi-confluent growth of colonies after overnight incubation. The use of an inoculum that yields semi-confluent growth has the advantage that an incorrect inoculum can easily be observed. A denser inoculum will result in reduced zones of inhibition and a lighter inoculum will have the opposite effect. The following methods reliably give semiconfluent growth with most isolates. NB. Other methods of obtaining semi-confluent growth may be used if they are shown to be equivalent to the following. 
The information in italics is tentative. Breakpoints will remain tentative for 1 year from when first published. a High-level gentamicin-resistant enterococci usually give no zone or only a trace of inhibition around gentamicin 200 mg discs. Occasionally, however, the plasmid carrying the resistance gene may be unstable and the resistance is seen as a zone of inhibition with a few small colonies within the zone. Retesting of resistant colonies results in growth to the disc or increased numbers of colonies within the zone. Zones should be carefully examined to avoid missing such resistant organisms. If in doubt, isolates may be sent to the reference laboratory for confirmation. 
The information in italics is tentative. Breakpoints will remain tentative for 1 year from when first published. The information in italics is tentative. Breakpoints will remain tentative for 1 year from when first published.
a Resistance to ceftriaxone, cefotaxime and cefixime has not been described. Isolates with chromosomally encoded reduced susceptibility to penicillin have slightly reduced zones of inhibition with these agents but they remain susceptible. Results for isolates with reduced zones around ceftriaxone, cefotaxime and cefixime discs should be confirmed by MIC determinations. b Quinolone resistance is generally reliably detected with nalidixic acid, however, there have been a few isolates that are resistant to ciprofloxacin yet susceptible to nalidixic acid in disc diffusion tests. The mechanism of resistance and the prevalence of these isolates in the UK are still under investigation. Isolates with reduced susceptibility to fluoroquinolones normally have no zone of inhibition with a 30 mg nalidixic acid disc. For organisms with nalidixic acid zone diameters 10-31 mm, a ciprofloxacin MIC should be determined if the patient is to be treated with this agent. The MIC breakpoint has been lowered to ensure that isolates with reduced susceptibility to ciprofloxacin are detected. d Test for b-lactamase. Use the tetracycline result to infer susceptibility to doxycycline. The information in italics is tentative. Breakpoints will remain tentative for 1 year from when first published. Note. Neisseria meningitidis is a category 2 pathogen, but should be regarded as a category 3 pathogen when heavy suspensions are used (DoH Hazard 29 January 1993). Consequently, suspension and dilution of organisms and inoculation of plates for susceptibility tests must be carried out in a class 1 safety cabinet. a Ampicillin and amoxicillin are used as indicator antibiotics to detect reduced susceptibility to penicillin. The recommendations given are for this purpose only; ampicillin and amoxicillin should not be reported. b Quinolone resistance is most reliably detected with nalidixic acid. Isolates with reduced susceptibility to fluoroquinolones have no zone of inhibition with nalidixic acid discs. in a spectrophotometer at a wavelength of 625 nm. The acceptable range for the standard is 0.08-0.13. Distribute the standard into screw cap tubes of the same size and volume as those used to prepare the test inoculum. Seal the tubes tightly to prevent loss by evaporation. Store protected from light at room temperature. Vigorously agitate the turbidity standard on a vortex mixer before use. Standards may be stored for up to 6 months, after which time they should be discarded. Alternatively, prepared standards can be purchased (e.g. from bioMérieux, Basingstoke, UK) but commercial standards should be checked to ensure that optical density is within the acceptable range as indicated above. 
Dilution of suspension adjusted to the turbidity of a 0.5 McFarland standard
See Table 4 for details. These suspensions should be used within 15 min of preparation.
Photometric standardization of turbidity of suspensions
A photometric method of preparing inocula was described by Moosdeen et al. 7 and from this, the following simplified procedure has been developed. 3.3.1 Suspend colonies (touch 4 -5 when possible) in 3 mL distilled water or broth in a 100 Â 12 mm glass tube (note that tubes are not reused) to give turbidity that is just visible. Do not leave the organisms standing in water. It is essential to get an even suspension. 3.3.2 Zero the spectrophotometer with a sterile water or broth blank (as appropriate) at a wavelength of 500 nm. Measure the optical density of the bacterial suspension. 
The information in italics is tentative. Breakpoints will remain tentative for 1 year from when first published. NB. B. thetaiotaomicron are inherently resistant to penicillin. There is poor relationship between MIC and zone of inhibition for inhibitor combinations and therefore recommendations are not given for co-amoxiclav or piperacillin/tazobactam. If the recommendations for B. fragilis are used for B. thetaiotaomicron, interpretation may be erroneous. a The recommendations have been established on the basis of the distribution for the 'wild susceptible' population as there are little published clinical data. Organisms that appear resistant by disc testing should have resistance confirmed by an MIC test and resistant isolates should be sent to the Anaerobe Reference Laboratory in Cardiff. The information in italics is tentative. Breakpoints will remain tentative for 1 year from when first published. a The recommendations have been established on the basis of the distribution for the 'wild susceptible' population as there are little published clinical data. Organisms that appear resistant by disc testing should have resistance confirmed by an MIC test and resistant isolates should be sent to the Anaerobe Reference Laboratory in Cardiff.
(The spectrophotometer must have a cellholder for 100 Â 12 mm test tubes. A much simpler photometer would also probably be acceptable. The 100 Â 12 mm test tubes could also be replaced with another tube/cuvette system if required, but the dilutions would need to be recalibrated.) 3.3.3 From Table 5 select the volume to transfer (with the appropriate fixed-volume micropipette) to 5 mL sterile distilled water. (As different spectrophotometers may differ slightly, it may be necessary to adjust the dilutions slightly to achieve semi-confluent growth with any individual set of laboratory conditions).
Direct susceptibility testing
The Working Party does not advocate direct susceptibility testing, as the control of inoculum is impossible. However, we are aware that this is a common practice in many laboratories and therefore we are suggesting methods that will achieve the correct inoculum size for a reasonable proportion of infected urines. The following methods have been developed and recommended by laboratories that use the BSAC method and we suggest adopting whichever method best suits individual laboratory working practice. If the inoculum is not correct and growth is not semi-confluent, or the culture is mixed, the test must be repeated.
3.4.1 Direct susceptibility testing of urines (i) Method 1: thoroughly mix the urine, place a 10 mL loop of urine in the centre of the susceptibility plate and spread with a dry swab. (ii) Method 2: thoroughly mix the urine, then dip a sterile cotton-wool swab in the urine and remove excess. Make a cross in the centre of the susceptibility plate and then spread with a sterile dry swab. If only small numbers of organisms are seen under the microscope, the initial cotton-wool swab may be used to inoculate and spread the susceptibility plate.
Direct susceptibility testing of positive blood cultures
The method suggested gives the correct inoculum size for a reasonable proportion of positive blood cultures. The method The information in italics is tentative. Breakpoints will remain tentative for 1 year from when first published. Note. These recommendations are for organisms associated with uncomplicated urinary tract infections. For complicated infections, systemic recommendations should be used. a If an organism is isolated from multiple sites, for example, from blood and urine, interpretation of susceptibility should be made with regard to the systemic site (e.g. if the blood isolate is resistant and the urine isolate susceptible, both should be reported resistant irrespective of the results obtained using interpretative criteria for urine isolates). b For agents not listed, criteria given for systemic isolates may be used for urinary tract isolates (Tables 7 and 9 ). c Direct susceptibility tests on urine samples may be performed as long as the inoculum gives semi-confluent growth. d In the absence of definitive organism identification, use the recommendations most appropriate for the presumptive identification, accepting that on some occasions, the interpretation may be incorrect. A more cautious approach is to use the systemic recommendations. e These interpretative standards apply only to Escherichia coli and Proteus mirabilis and not to species that have chromosomal penicillinases (Klebsiella spp.) or those that typically have inducible AmpC enzymes (e.g. Enterobacter spp., Citrobacter spp. and Serratia spp.). The identification of Enterobacteriaceae to species level is essential before applying expert rules for the interpretation of susceptibility.
f Cefalexin results may be used to report susceptibility to cefadroxil. g Fosfomycin/glucose-6-phosphate. h Fosfomycin-the susceptibility of Proteus spp. that swarm up to the disc-can be difficult to interpret. i Isolates of Escherichia coli and Klebsiella spp. that produce ESBLs often appear susceptible to mecillinam in vitro, but clinical efficacy against these organisms is unproven.
varies according to the Gram reaction of the infecting organism.
Gram-negative bacilli
Using a venting needle, place one drop in 5 mL of sterile water and use this to inoculate Iso-Sensitest or equivalent agar.
Gram-positive organisms
It is not always possible to accurately assume the genera of Gram-positive organisms from the Gram's stain. However, careful observation of the morphology, coupled with some clinical information, should make an 'educated guess' correct most of the time.
Staphylococci and enterococci
Using a venting needle, place three drops in 5 mL of sterile water and use this to inoculate Iso-Sensitest or equivalent agar.
Pneumococci, 'viridans' streptococci and diptheroids
Using a venting needle, place one drop in the centre of an Iso-Sensitest or equivalent agar supplemented with 5% horse blood and spread evenly over the entire surface of the plate. If the inoculum is not correct and growth is not semi-confluent, or the culture is mixed, the test must be repeated.
Inoculation of agar plates
4.1 Use the adjusted suspension within 15 min to inoculate plates by dipping a sterile cotton-wool swab into the suspension and remove the excess liquid by turning the swab against the side of the container. Spread the inoculum evenly over the entire surface of the plate by swabbing in three directions. Allow the plate to dry before applying discs. Note that if inoculated plates are left at room temperature for extended times before the discs are applied, the organism may begin to grow, resulting in reduced zones of inhibition. Discs should therefore be applied to the surface of the agar within 15 min of inoculation.
Use of rotary platers for susceptibility testing
Rotary platers can be used for inoculating susceptibility tests, but care must be taken. The swab must be moved at an even pace to ensure that the inoculum is semi-confluent and that no gaps are present between the swab streaks.
5 Antimicrobial discs 
Storage and handling of discs
Loss of potency from discs will result in reduced zones of inhibition. To avoid loss of potency as a result of improper handling, the following procedures are essential. 5.2.1 Store discs in sealed containers with a desiccant and protected from light (this is particularly important for some lightsusceptible agents such as metronidazole, chloramphenicol and the quinolones). 5.2.2 Store stocks at 2208C except for drugs known to be unstable at this temperature (refer to the disc manufacturer's instructions on disc storage). If this is not possible, store discs at ,88C. 5.2.3 Store working supplies of discs at ,88C. 5.2.4 To prevent condensation, allow discs to warm to room temperature before opening containers. 5.2.5 Store disc dispensers in sealed containers with an indicating desiccant. 5.2.6 Discard any discs on the expiry date shown on the side of the container.
Application of discs
Discs should be firmly applied to the surface of an agar plate that has been dried previously. The contact with the agar should be even. A 90 mm plate will accommodate six discs without unacceptable overlapping of zones.
Incubation
6.1 If the plates are left at room temperature after discs have been applied, larger zones of inhibition may be obtained, compared with zones produced when plates are incubated immediately. Plates therefore should be incubated within 15 min of disc application.
Conditions of incubation
Conditions of incubation for different organisms are summarized in Table 6 . Stacking plates too high in the incubator may affect results owing to uneven heating of plates. The efficiency of heating of plates depends on the incubator and the racking system used. Control of incubation, including height of plate stacking, should therefore be part of the laboratory's Quality Assurance programme.
7 Measuring zones and interpretation
Acceptable inoculum density
The inoculum should give semi-confluent growth of colonies on the susceptibility plate, within the range illustrated in Figure 1 .
Measuring zones
7.2.1 Measure the diameters of zones of inhibition to the nearest millimetre (zone edge should be taken as the point of inhibition as judged by the naked eye) with a ruler, callipers or an automated zone reader. 4 When using cefoxitin for the detection of methicillin/ oxacillin/cefoxitin resistance in S. aureus, measure the obvious zone, taking care to examine zones carefully in good light to detect minute colonies that may be present within the zone of inhibition (Figure 2 ). 7.2.5 Confirm that the zone of inhibition for the control strain falls within the acceptable ranges in Tables 27 -31 before interpreting the test. 7.3 A template can also be used for interpreting zone diameters ( Figure 3) . A program for preparing templates is available from the BSAC (http://www.bsac.org.uk). The test plate is placed over the template and the zones of inhibition are examined in relationship to the template zones. If the zone of inhibition of the test strain is within the area marked with an 'R', the organism is resistant. If the zone of inhibition is equal to or larger than the marked area, the organism is susceptible.
Susceptibility testing of Brucella species
Brucella spp. are Hazard Group 3 pathogens and all work must be performed in containment level 3 accommodation. The antimicrobial agents most commonly used for treatment are doxycycline, rifampicin, ciprofloxacin, tetracycline and streptomycin and, from the limited information available, there is little or no resistance to these drugs. Brucella spp. are uncommon isolates and interpretative standards are not available. As Brucella spp. are highly infectious, susceptibility testing in routine laboratories is not recommended.
Susceptibility testing of Legionella species
Legionella spp. are slow growing and have particular growth requirements. Disc diffusion methods for susceptibility testing are unsuitable. Susceptibility should be determined by agar dilution MICs on buffered yeast extract agar with 5% water-lysed horse blood. 1 The antimicrobial agents commonly used for treatment are macrolides, rifampicin and fluoroquinolones. Validated MIC breakpoints are not established for Legionella spp. If results for test isolates are within range of the normal wild-type distribution, given in Table A2 , clinical susceptibility may be assumed.
